» Articles » PMID: 7704507

Postoperative Adjuvant Therapy for Non-small Cell Lung Cancer: a Consensus Report

Overview
Journal Lung Cancer
Specialty Oncology
Date 1994 Nov 1
PMID 7704507
Citations 3
Authors
Affiliations
Soon will be listed here.
Citing Articles

Interpreting trial results in light of conflicting evidence: a Bayesian analysis of adjuvant chemotherapy for non-small-cell lung cancer.

Miksad R, Gonen M, Lynch T, Roberts Jr T J Clin Oncol. 2009; 27(13):2245-52.

PMID: 19307513 PMC: 2674005. DOI: 10.1200/JCO.2008.16.2586.


Angiogenesis and the efficacy of postoperative administration of UFT in pathologic stage I non-small cell lung cancer.

Tanaka F, Yanagihara K, Otake Y, Miyahara R, Wada H Cancer Sci. 2004; 95(4):371-6.

PMID: 15072598 PMC: 11158538. DOI: 10.1111/j.1349-7006.2004.tb03218.x.


p53 status predicts the efficacy of postoperative oral administration of tegafur for completely resected non-small cell lung cancer.

Tanaka F, Yanagihara K, Ohtake Y, Miyahara R, Kawano Y, Fukuse T Jpn J Cancer Res. 1999; 90(4):432-8.

PMID: 10363582 PMC: 5926087. DOI: 10.1111/j.1349-7006.1999.tb00766.x.